| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78ca80ad4b743c901ec136b21263f093 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29L2031-7544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29K2105-0044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2207-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G2125-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29K2069-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C45-0001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K5-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L69-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C33-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K5-5313
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K5-103 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B29L31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B29K69-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G64-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B29C33-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K5-103 |
| filingDate |
2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0626af8b7a3ff5b2bac9eaafcb8297c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb55e2325cb26ce27302ca84bf4ce88a |
| publicationDate |
2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107921672-A |
| titleOfInvention |
Use of dual release agents for medical device applications |
| abstract |
The present disclosure relates to medical device components having a thickness of about 4 mm or less, wherein the medical device components utilize polycarbonate polymers and from about 0.2 wt % to about 0.5 wt % of pentaerythritol tetrastearate and from about 0.05 wt% to about 0.3 wt% glyceryl monostearate is manufactured by an injection molding process; wherein the pentaerythritol tetrastearate is derived from biological sources. |
| priorityDate |
2015-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |